Chemist Dr. Ievgen Donskyi plans to develop alternative to conventional antibiotics with his junior research group "PathoBlock"
A new junior research group at Freie Universität Berlin, which will investigate the production of biodegradable antiviral and antibacterial materials, with one of the goals of synthesis being new alternatives to conventional antibiotics, will receive a total budget of more than 1.8 million euros from the German Federal Ministry of Education and Research (BMBF) over the next five years. The "PathoBlock" research group is led by chemist Dr. Ievgen Donskyi at the Institute of Chemistry and Biochemistry, Freie Universtität Berlin, and includes scientists from the fields of chemistry, biology, veterinary medicine, and engineering.
...TO READ THIS ARTICLE, CREATE YOUR ACCOUNT
And extend your reading, free of charge and with no commitment.
